Non-Invasive Prenatal Testing (NIPT) Market 2020 Key Trend, Future Opportunities Forecast to 2030 - Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche
Market Industry Reports (MIR) has published a new report titled “Non-Invasive Prenatal Testing (NIPT) Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global non-invasive prenatal testing market accounted for over US$ 1.5 Bn in 2019. It is anticipated to grow at a CAGR of approximately 16.2% from 2019 to 2030.
The new study made on Non-Invasive Prenatal Testing (NIPT) market includes crucial information on market share, market size, and growth rate for the forecast period 2020 – 2030. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics.
COVID-19 Impact:
The industrial report mentions about the influence of the ongoing COVID-19 pandemic. The outbreak has caused disturbances in several industries and has hammered the logistics, resulting in delayed deliveries and cancellation of product demand. The Non-Invasive Prenatal Testing (NIPT) report proficiently explains about the resulting factors and concerns of manufacturers. Researchers have also well-explained about how the producers and providers will tackle with the ongoing epidemic and the key strategies to be adopted post pandemic for turning their businesses back to normal.
Major Key Players of the Non-Invasive Prenatal Testing (NIPT) Market are:
Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, QIAGEN, BGI, Agilent Technologies, Inc., Natera, Inc., YOURGENE HEALTH, CENTOGENE N.V., and PerkinElmer Inc., among others.

Comments
Post a Comment